SPRUCE BIOSCIENCES, INC.

For the period ended Mar 31, 2026. Filed May 13, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

SPRB$46.55+9.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Balance Sheets

(in thousands, except share and per share amounts)

	March 31,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$54,080	$48,906
Prepaid expenses	864	353
Other current assets	88	2,853
Total current assets	55,032	52,112
Right-of-use assets	595	666
Other assets	539	243
Total assets	$56,166	$53,021
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$2,683	$943
Accrued expenses and other current liabilities	8,101	9,143
Debt, current portion	1,000	—
Total current liabilities	11,784	10,086
Lease liabilities, net of current portion	332	419
Debt, net of current portion	5,464	—
Warrant liability	3,938	—
Total liabilities	21,518	10,505
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of March 31, 2026 and December 31, 2025	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 1,372,278 and 1,372,043 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	336,148	331,750
Accumulated deficit	(301,500)	(289,234)
Total stockholders’ equity	34,648	42,516
Total liabilities and stockholders’ equity	$56,166	$53,021

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.